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ABSTRACT 
 
 
Employing a novel two-dimensional computational model we have simulated the 
feedback between angiogenesis and tumor growth dynamics. Analyzing vessel formation 
and elongation towards the concentration gradient of the tumor-derived angiogenetic 
basic fibroblast growth factor, bFGF, we assumed that prior to the blood vessels reaching 
the tumor surface, the resulting pattern of tumor growth is symmetric, circular with a 
common center point. However, after the vessels reach the tumor surface, we assumed 
that the growth rate of that particular cancer region is accelerated compared to the tumor 
surface section that lacks neo-vascularization. Therefore, the resulting asymmetric tumor 
growth pattern is biased towards the site of the nourishing vessels. The simulation results 
show over time an increase in vessel density, a decrease in vessel branching length, and 
an increase in fracticality of the vascular branching architecture. Interestingly, over time 
the fractal dimension displayed a sigmoidal pattern with a reduced rate increase at earlier 
and later tumor growth stages due to distinct characteristics in vessel length and density. 
The finding that, at later stages, higher vascular fracticality resulted in a marked increase 
of tumor slice volume provides further in silico evidence for a functional impact of 
vascular patterns on cancer growth.  
 
Keywords: Tumor growth, angiogenesis, computational modeling, fractal dimension 
analysis 
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1. INTRODUCTION 
 
Despite substantial progress in characterizing the mechanisms that control tumor 
angiogenesis, following the seminal work by Folkman (1971) and others, the dynamical 
regional feedback between tumor growth and neovascularization is still not fully 
understood. Since this is due, in large parts, to the complexity of the biological processes 
involved, in silico modeling, which allows for reproducibly altering parameters 
separately or in combination, can contribute here. Thus, not surprisingly, there have 
already been a number of theoretical studies on tumor angiogenesis in which continuum 
or discrete models were used.  
 
In continuum models, only the distribution of endothelial cells is considered while 
vascular networks are not included. Chaplain et al. (1996, 1997) then presented two- and 
three-dimensional models of tumor angiogenesis using a ‘hybrid’ by combining both 
discrete and continuum methods. To determine the movement of the sprouting tips of 
endothelial cells, the authors solved partial differential equations for the concentration of 
a so called tumor angiogenesis factor (TAF), of fibronectin and endothelial cell density 
by using the finite difference method. The formation and growth of vessel sprouts were 
approximated using a stochastic process that was based on the distribution of both TAF 
and fibronectin; yet, Chaplain et al. also assumed that TAF secretion was constant over 
time. The numerical solutions of such models can be compared to experimental data, and 
cellular mechanisms can be incorporated readily into new mathematical models. Alarcon 
et al. (2003) then developed a mathematical model which showed the influence of blood 
flow and red blood cell heterogeneity on tumor growth and angiogenesis. Furthermore, 
Serini et al. (2003) provided a model that included chemoattraction and cell-cell 
interaction for identification of key parameters in the early stages of the vascular network 
assembly. Recently, Zheng et al. (2005) have computed tumor angiogenesis using a 
formulation similar to Chaplain, but they modeled the nutrient distribution assuming a 
spatial variation of TAF within viable and necrotic tumor regions. In this context, we note 
also that Gazit et al. (1995) already employed fractal theory to compute the vessel 
networks that surround a tumor and computed the hemodynamics within these vessel 
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structures. Grizzi et al. (2005) introduced the surface fractal dimension to explain the 
geometric complexity of cancerous vascular networks. They showed that the surface 
fractal dimension significantly depends on the number of vessels and their patterns of 
distribution. However, these previous studies restricted growth to the discrete mesh 
points of the computational lattice. Conversely, Tong et al. (2001) developed a two-
dimensional angiogenesis model in which they assumed a biased random motion of 
endothelial cells in an effort to examine the transport of angiogenic factors in the rat 
cornea; vessel growth in their study was independent of the computational mesh unlike in 
the previous approaches and as such, tumor angiogenesis was implemented in a more 
realistic and efficient manner. We add that another detailed model of tumor angiogenesis 
has been proposed by Levine et al. (2001), which included the biochemical processes that 
involve angiostatin, the biased movement of endothelial cells, and transport diffusion 
equations of molecular species in porous media. Finally, a specific inclusion of cell 
metabolism has been made by Scalerandi et al. (2001) in an effort to model the local 
interaction between cells and the vascular system. 
  
However, one of the main limitations of all these previous works is that the quantity of 
angiogenic factors that are released from the tumor cells is assumed to be constant. This 
assumption is rather unrealistic, since the increase in tumor volume and thus the quantity 
of angiogenic factors that are released by it should be linked, i.e. vary dynamically. We 
have therefore introduced a tumor angiogenesis model adopting a pattern of a growing 
brain tumor (Shim et al., 2005). In this previous study, the angiogenetic factor bFGF was 
secreted with a time varying pattern and led to symmetric cancer growth. The model’s 
primary shortcoming was that it failed to close the feedback loop that the vessel’s 
emergent architecture should have on regional tumor growth behavior. Therefore, in this 
study here, we present a computational model of tumor-induced angiogenesis that now 
includes this crucial link between vessel architecture and regional tumor growth 
dynamics. As before, we have again adopted the model of a virtual brain tumor that was 
presented in Kansal et al. (2000) and employed it for the pre-vascular stage, i.e. prior to 
any blood vessel reaching the expanding tumor. However, a different growth model is 
then applied after the first vessel reaches the tumor surface. We chose basic fibroblast 
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growth factor (bFGF) as angiogenesis factor because the concentration of bFGF is 
reportedly proportional to the increase in malignancy and vascularity of high-grade 
gliomas (Takahashi et al., 1992). Some parameter values for bFGF-induced angiogenesis 
were obtained from Tong et al. (2001), whereas e.g. the 50 pg/105 cells per 24 h as bFGF 
production rate of human U87 glioma cells was taken from Zagzag et al. (1990). The 
finite element method was used to solve the convection-diffusion equation for the 
concentration of bFGF; this method is a convenient way in dealing with the complex 
geometry of real biological phenomena. Both vessel formation and sprout elongation 
were simulated using a stochastic process, much like in the aforementioned studies.  
 
 
2. MODEL 
 
General setup 
 
The two-dimensional setup is depicted in Figure 1 and consisted of a 171 x 171 
rectangular mesh lattice.  
 
Figure 1 
Table 1 
 
In here, Ldomain and RPV represent the total computational domain and the radius of the 
parent vessel measured from the center of the tumor, respectively. The computational 
domain consists of three regions: necrotic and viable tumor regions, and surrounding 
healthy tissue. For the simulation of tumor growth in the computational domain we used 
the following assumptions for these regions:  
 
1. In the viable region (ΩV), bFGF is produced according to the tumor’s dynamic growth 
pattern as reported for the case of a virtual brain tumor by Kansal et al. (2000; Table 2). 
Eventually, the secreted bFGF diffuses also into the healthy non-tumorous tissue (and 
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into the tumor’s necrotic region). As such, there is bFGF production, diffusion, and time-
elapsed decay in this viable region. 
 
2. In the necrotic region (ΩN), we assume the production of bFGF to be zero; however, as 
stated above, the bFGF produced in the viable region of the tumor diffuses to the necrotic 
region and decays over time. 
 
3. In the healthy tissue region (ΩH), we assume that there is diffusion of bFGF, decay of 
bFGF due to degradation and uptake by endothelial cells. For the diffusion boundary (ξD), 
we also assumed a no flux condition similar to Tong et al. (2001). 
 
 
Transport equations for basic fibroblast growth factor (bFGF) 
 
The transport equation of bFGF within the three regions depends on the characteristics of 
each domain. A general governing equation for bFGF transport can be derived as follows: 
 
 
2 2
1 p 2 3 42 2
C C CQ D k C u L C
t x y
⎛ ⎞∂ ∂ ∂= µ + µ ⋅ + − µ ⋅ − µ ⋅ ⋅⎜ ⎟∂ ∂ ∂⎝ ⎠      (1) 
 
where Qp, C, D, k, u, and L represent the bFGF production rate, the concentration of 
bFGF, the diffusion coefficient of bFGF, the rate constant of bFGF degradation, the rate 
constant of bFGF uptake, and the vessel density (defined as the total vessel length per 
unit area), respectively. The constants used are listed in Table 2. The coefficients µ1, µ2, 
µ3, and µ4 represent on-off style identifiers (set as 0 or 1) and vary according to regional 
characteristic for the bFGF transport as described in Table 3. Qp is non-zero in the viable 
tumor region whereas bFGF uptake by endothelial cells is zero in this region. The 
transient value of Qp is given in the last row of Table 1 based on the experimental 
observation that human U87 glioma cells produce 50 pg of bFGF (per 105 cells) over 24 h  
(Zagzag et al., 1990) and the time-dependent viable tumor cell number listed in Table 1. 
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The bFGF diffusion coefficient D was taken from Tong et al. (2001) and assumed to be 
constant over all regions.  
 
Table 2 
Table 3 
 
For the computational domain, application of the Galerkin finite element discretization 
for Eq. (1) yielded the matrix equation with the coefficient matrix, the vector of unknown 
nodal variables of C and the external driving forces. This matrix equation was solved 
using an incomplete conjugate gradient method (Kershaw, 1978). 
 
 
Sprout formation and elongation  
 
Within the surrounding normal tissue, the initial response of the endothelial cells to bFGF 
is chemotactic, i.e. migration along the bFGF-concentration gradient and thus towards the 
angiogentic factor-releasing tumor. This process leads to the formation of capillary 
sprouts that continue to grow in length towards the growing tumor, guided by the motion 
of the leading endothelial cell at the tip of the sprout. Much like Tong et al. (2001), we 
also introduced a threshold function f(C) to account for the effect of the bFGF 
concentration on vessel sprout formation and elongation as follows: the values of the 
function are zero below the threshold concentration Ct and increase exponentially with a 
limiting value of 1. The value of Ct is also represented in Table 2. To approximate sprout 
formation, we assume that it is a stochastic process with biased angiogenesis pattern 
towards the tumor. The probability n  for the formation of one sprout from a vessel 
segment in a time interval between t and t+∆t is proportional to ∆t, the segment length ∆l, 
and the threshold function. Here, the proportional constant, Smax, denotes a rate constant 
that determines the maximum probability of sprout formation per unit time and vessel 
length. The growth of a sprout is determined by the locomotion of its tip, while the 
geometry of a sprout depends on the tip trajectory (Tong et al., 2001). Specifically, the 
direction of sprout growth at each time step depends on two unit vectors: the direction of 
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growth in the previous time step and the direction of the concentration gradient of the 
angiogenic factors. This is due to the fact that sprout growth depends on endothelial cell 
migration, which has a tendency to persist in the same direction as in the previous time 
step. To reflect the effect of extracellular matrix on (haptotacic) cell migration, we 
assume that the angle of deviation, θ, is between π/2 and –π/2 and that tanθ follows a 
Gaussian distribution with a mean of zero and a variance of σ. A detailed description of 
sprout formation and elongation can be found in Tong et al. (2001). The constants 
represented in the equations are described in Table 2. 
 
 
Brain tumor growth model 
 
We employ a previously developed brain tumor model that has four distinct growth 
stages within a virtual patient, namely multicellular spheroid, 1st detectable lesion, 
diagnosis, and death (Kansal et al., 2000). To approximate data in each of these growth 
stages, we used the following well known Gompertz equation: 
 
 ( )⎟⎠
⎞⎜⎝
⎛ −−= )Btexp(1
B
AexpVV 0        (2) 
 
where A and B are parameters, and 0V  is the initial tumor volume. The quantity of bFGF 
release at each of the two ‘early’ growth stages is summarized in Table 1. Assuming that 
tumor growth would be spherical during the avascular state but would then develop a 
biased shape towards the parent vessel during the vascular state, we then investigated a 
1.0-mm-thick, circular slice of the tumor for our 2D model. As a first approximation, we 
have calculated the amount of bFGF at each of the two stages for the total amount of 
viable tumor cells (i.e., proliferative and quiescent) using the cell numbers reported by 
Kansal et al. (2000)1. Further, as soon as the first vessel reaches the tumor surface, we 
assume that the part of the tumor adjacent to this vessel obeys vascularized tumor growth 
                                                 
1  This model focused on describing the tumor’s solid core, hence included proliferative and non-
proliferative alive as well as dead tumor cells, yet did not simulate migrating tumor cells explicitly.  
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dynamics. While this particular tumor region will therefore display a rather rapid radius 
increase, the rest of the tumor, non-vascularized, continues to follow the slower avascular 
dynamics of the spheroid stage. This implements the concept that tumor growth is largely 
symmetrical before the first vessel branch makes contact with the tumor surface; 
thereafter, growth is arguably more asymmetrical for that particular tumor region. 
Reflecting early experimental work by Folkman (1971), the ‘first’ vessel branch was set 
to reach the tumor surface when the radius of the tumor is 1.0 mm; afterwards, the tumor 
begins to grow eccentrically since biased towards the nourishing blood vessel. For 
computation of the asymmetric growth, we assumed that there are two regions as shown 
in Figure 2: vascularized and non-vascularized regions. 
 
Figure 2 
Figure 3 
 
Note that there are several regional tumor centers developing in the vascularized region, 
from which tumor growth is augmented; in this paper we however keep the rate at which 
the radius increases, which is a variable computed from the time-varying slice volume 
data, uniform for all these regional tumor centers (follow-up work will relax this 
assumption to better reflect the emergence of tumor heterogeneity). Figure 3 represents 
the overall tumor radius computed from the Gompertz equation (Eq. 2) with the 
parameters adjusted to match the data listed in Table 1. Here, the tumor slice volume is 
computed from this radius with a constant slice thickness of 0.1 mm. The main 
assumption of the asymmetric tumor growth in the present study is that the volume 
growth difference between vascular and avascular state contributes to the asymmetric 
growth of the tumor after the 1st vessel reaches the tumor surface. The following 
paragraphs briefly describe the schematic behind the asymmetric growth procedure 
during the vascular state per each time step: 
 
1. When the 1st blood vessel reaches the tumor surface, the sites that are ‘touched’ by 
these vascular branches will be specified as local tumor centers. In Figure 2(a), C0 
denotes the initial tumor center that is the origin of symmetric tumor growth whereas the 
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others (C1, C2, …, Cn) comprise these local tumor centers. That is, the non-vascularized 
region maintains the initial tumor center, C0, whereas the vascularized regions continue 
with local tumor centers, i.e., C1, C2, …, Cn. 
 
2. After elapse of one time step, the tumor boundary expanded into the dotted line in 
Figure 2(a). Here, t stands for time and its superscript denotes time index. In this first 
approximation, we assume that the local tumor centers have the same radius increase (δ) 
whereas the non-vascularized region distinguishes itself through a radius increase of δ0. 
This radius increase of δ0 is obtained from curve A in Figure 2(b). The radius increase δ 
in the vascularized region (curve B, Figure 2(b)) was obtained to satisfy the area of the 
vascularized tumor region equal to the computed tumor slice volume of the Gompertz 
equation curve in Figure 3.  
 
3. For the vascularized tumor area it then follows that it sustains augmented volumetric 
growth and thus harbors more viable cancer cells.  
 
4. Consequently, this gain in viable tumor cells leads to an increase in bFGF production 
in the very same vascularized tumor area. 
 
5. Lastly, this increased bFGF secretion recruits even more blood vessels towards an 
already vascularized area and thus ‘closes’ the feedback loop back to (3.). 
 
 
Branching pattern analysis 
 
To quantify the vessel branching patterns within the computational domain, we calculated 
the number of branching points within a given region of interest (ROI, see Figure 1). A 
ROI represents a rectangular region with 2.5mm × 2.5mm and a branching point is 
defined as the site at which one vessel splits into two new branches. For each ROI, the 
total number of branching points within the ROI was calculated. To account for temporal 
variation of vessel growth, we considered the average branching length, number of 
Shim E.B., Kim Y.S. & Deisboeck T.S.: 2D FEM Tumor Angiogenesis Model 
 11
branching points and vessel density in the ROI. Also the fractal dimension analysis for 
the vessel structure is analyzed to track the dynamic change in vessel formation. In brief, 
the fractal dimension in this study is based on the box counting method that is derived 
from the theoretical works by Baish and Jain (2000). A total of 20 different boxes with a 
specific width of the total computational domain are used. We then computed the 
corresponding box numbers to cover all vessels in the domain and this was plotted 
according to the box numbers. The linear slope of the logarithmic graph represents the 
fractal dimension. 
 
 
3. RESULTS 
 
We have implemented the algorithm using Fortran. One run took approximately 28 hrs 
using a Pentium 586 PC with 2.33 GHz clock speed. To investigate the effect of the 
location of the initial vessel formation on the emerging vascular network, we have run 10 
cases with a random choice in the initial sprout location. The circumferential angles of 
these locations are listed in the Table 4. However, for brevity we focus in the following 
section on the case with θ1 = -103◦, θ2 = -135◦, θ3 = -168◦ (except for Figure 10, as stated). 
In the following, we describe the results in detail. 
 
Table 4 
 
To begin with, the tumor-secreted bFGF concentration distribution (Figure 4) displayed a 
radial isotropic gradient at t = 1,656 hrs and 2,200 hrs (Figs. 4(a)-(b)) when the vessels 
were still rather short. However, after the vessel architecture has expanded and moved 
closer to the tumor surface, the overall endothelial cells’ bFGF consumption increased 
markedly and, consequently, the radial gradient of the concentration distribution of bFGF 
ceased to diffuse isotropically. Specifically, the concentration of bFGF decreased on the 
tumor side adjacent to the blood vessels while it remained relatively high on the opposite 
side (Figs. 4(c)-(e)). The plots also show that due to its ongoing production the maximum 
value of the bFGF concentration increases prior to the first vessel branch reaching the 
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tumor surface (top value in color bar, Figs. 4(a)-(b)). While the aforementioned 
endothelial consumption leads to a temporary reduction of the maximum bFGF value 
(Figs. 4(c)-(d)), overall, the bFGF concentration in the tumor slice volume increases 
again later on (Figs. 4(e)-(f)).   
 
Figure 4 
Figure 5 
 
It is noteworthy that, although originating at the same time point, the middle branch 
showed relatively less branching due to ‘competition’ with the others for limited amounts 
of released bFGF. In our simulation, the 1st vessel branch reaches the tumor surface at t = 
2,590 hrs (Figure 4(c); t = 2,800 h) while at t = 3,800 hrs, numerous vessel branches 
close to the tumor surface yield a so-called “brush-border effect” with higher vessel 
densities within that tumor region (Figure 4(f)). 
 
Structural characteristics of tumor angiogenesis are then depicted in Figure 5. First, we 
note that the branching length diminishes exponentially over time (Figure 5(a)) while the 
number of branching points and the overall vessel density show an exponential increase 
(Figs. (b)-(c)). The results therefore confirm that the number of vessel branches increased 
dramatically as soon as the first vessels reached the tumor surface (t > 2,590 hrs), 
enabling the transition to the vascular growth stage.  
 
Figure 6 
Figure 7 
Figure 8 
 
Analysis of the vessel architecture’s fractal dimension is represented in Figure 6, which 
illustrates a gradual increase over time. Specifically, during the avascular state (Figs. 
6(a)-(b)) the fractal dimension is less than 1. However, as more vessels reach the tumor 
surface, the dimension increases beyond 1 and reaches 1.4 at t = 3,800 hrs. While Figure 
7 summarizes this change of fractal dimension over time, Figure 8 displays the variation 
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of the fractal dimension versus the tumor slice volume. The latter result demonstrates the 
nourishing impact vascularization has when, at a fractal dimension of 1.2, the tumor’s 
growth rate is dramatically augmented. Interestingly, the vessel architecture’s fractal 
dimension appears to approach an asymptotic value at larger tumor slice volumes. Taken 
together with Figure 5, this indicates that at later stages, the emergent vascular 
infrastructure seems to rely increasingly on relatively short and straight vessels.   
 
Figure 9 
Figure 10 
 
To assess the effect of the variance in the sprout’s deviation angle (Table 2) on 
angiogenesis, and thus to evaluate the robustness of the results, we simulated two more 
cases for the variance σ = 0.3 (Figure 9(a)) and σ = 0.7 (Figure 9(c)), respectively, and 
compared it with the standard case of σ = 0.5 (Figure 9(b)). While, according to the 
increase of variance in the deviation angle, the circumference length occupied by the 
vascularized tumor region indeed increased, we found no significant change in the fractal 
dimension (Figure 10), indicating that the latter is invariant to the deviation angle.  
 
Figure 11 
 
Finally, to investigate the dependency of the fractal dimension on the tumor radius at the 
time the 1st vessel docks, we simulated three more cases with varying tumor radii (Figure 
11). Similar to the standard case depicted in Figure 7, the fractal dimension increased 
again yet was saturated at later times. While the lag phase seems to last longer (Figure 
11(c)) for larger tumor radii, the curve’s overall sigmoidal pattern is robust. 
 
 
4. DISCUSSION & CONCLUSIONS 
 
A more detailed understanding of tumor angiogenesis is of paramount interest for clinical 
cancer research in an effort to develop more effective anticancer therapies (for a review 
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see e.g. Carmeliet & Jain, 2000). We firmly believe that in silico research can help guide 
experimental works and so, in here, we have presented a new computational method to 
simulate tumor angiogenesis in two dimensions. As an example for angiogeneic factors, 
we used basic fibroblast growth factor or bFGF. Its expression reportedly correlates with 
the degree of malignancy and vascularity in gliomas (Takahashi et al., 1992). For the 
analysis of the spatio-temporal distribution of bFGF, its conservation equation was solved 
using the finite element method. Unlike in previous computational and mathematical 
studies, here, we have taken into account the feedback between vascular supply and 
tumor growth. Specifically, employing data from a previous study that describes the 
virtual growth of a malignant brain tumor over several scales of interest (Kansal et al., 
2000) we have focused on monitoring the dynamics of the tumor’s bFGF production and 
its effect on the emergent vessel patterns.  
 
The simulation results confirm that a tumor-secreted angiogeneic factor influences the 
patterns of vascular architecture and that such dynamic neovascularization can impact 
tumor growth patterns (Figures 4, 8), thus closing the assumed feedback loop. While 
these results are somewhat expected given the setup of the underlying algorithm, to our 
knowledge, an in silico model that simulates these relationships properly has not been 
developed yet. Aside from this technical advancement, the fact that the results show a 
clear shift in vessel structure, i.e. fracticality, at the transition to the vascular tumor 
growth stages deserves a more detailed discussion. For instance, applying West et al.’s 
Universal scaling law (2001) to tumors, Guiot et al. (2003) have previously argued for a 
dynamic behavior of the so called scaling exponent ‘p’ (Guiot et al., 2005). Specifically, 
that work conjectured that scaling exponent values which exceed ¾ (and are thought to 
be conveyed by angiogenesis) can be explained with surface-diffusion supplementing 
neovascularization as prevailing tumor nourishing supply mechanism. These theoretical 
considerations are well matched now with the result from our computation here, where 
vessel branching indeed starts at about t = 2,200 hrs (Figure 4(b)) with a fractal 
dimension of about 0.71 (Figures 6(b), 7) before it increases well over 1. Taken together, 
we argue that the scaling exponent p at which angiogenesis starts is indeed between 2/3 
and 3/4. Interestingly, we also find that over time the fractal dimension shows a rather 
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robust sigmoidal pattern with a saturated curve at the earlier and later stages (Figures 10 
and 11). That is, at the initial stage the fractal dimension slowly increases because the 
few generated vessel branches are comparably long and straight. This period is followed 
by a phase of sharp increase in fracticality, prior to displaying a more saturated pattern at 
the later, established vascular stage which operates with a large number of rather short, 
straight and space-filling vessels. This not only hints at the fact that vessel fracticality is 
not limitless but also suggests that – at least temporarily, during the angiogenetic switch – 
a more heterogeneous neovascular architecture may increase its functional efficiency to 
nourish: During that period, a lesser increase in fracticality, by concomitantly utilizing a 
larger number of shorter and non-fractal microvessels, yields a more sustained increase in 
tumor slice volume (Figure 8), indicated also by the larger bFGF concentration this gain 
in viable tumor tissue can generate (Figure 4(f)). It will be intriguing to assess the 
robustness of this finding after ‘functionality’ has been introduced explicitly in form of 
accounting first for a (variety in) vessel diameter (Wesseling et al., 1998) to then model 
(heterogeneity in) tumor blood flow and blood volume conveyed by the discrete vascular 
architecture. One goal here would be to in silico simulate and analyze the at least for 
glioblastoma reported (Parikh et al., 2004) correlation between relative cerebral blood 
volume and abnormal vessel turtuosity (Bullitt et al., 2004). Given the significant effort 
that is currently underway clinically to image angiogenesis (for a recent review see e.g. 
Miller et al., 2005), any such interdisciplinary efforts may have substantial applicability.    
 
Admittedly, as a first approximation the model has to rely on multiple simplifications, 
and future work will need to add complexity on the molecular level both on the tumor 
and endothelial cells side to enable incorporation of many additionally relevant 
biomedical data. Secondly, enriching the ‘available’ cancer cell phenotypes by 
considering cell motility explicitly will be an important step, particularly also for 
modeling the spatio-temporal expansion of primary brain tumors more realistically. 
Lastly, implementing a more specific treatment of the biomechanical properties of tumor 
and surrounding tissue (see e.g. Boucher et al., 1996) as well as moving the model into 
three-dimensions represent other avenues that should be pursued. Nonetheless, we argue 
that if properly expanded this in silico platform will offer an exciting new tool to 
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integrative tumor biology research in that it allows for rapid development and refinement 
of experimentally testable hypotheses related to cancer angiogenesis.  
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FIGURE CAPTIONS 
 
 
Figure 1. Two-dimensional model geometry. Here, Ldomain is the overall computational 
length. Depicted are also the location of the parent vessel inside of the domain and the 
diffusion boundary. RPV represents the radius of the parent vessel location from the tumor 
center. This figure also illustrates the region of interest (ROI) that is utilized in the 
analysis (see Figure 5 (c)). 
 
Figure 2. Schematic of the computational method to calculate the asymmetric tumor 
growth behavior. Here, the vascularized region displays a relatively faster growth rate 
than the non-vascularized parts of the tumor. This growth rate is determined by the 
condition to fit the slice volume of previously reported data (Kansal et al., 2000). (a) 
Asymmetric growth pattern comprise vascularized and non-vascularized tumor regions; 
(b) Schematic of the slice volume growth rate for the case without (curve A) and with 
angiogenesis (curve B), for the two different growth states, avascular and vascular 
(compare with “spheroid” and “1st detectable lesion” stages described in Table 1 (values 
from Kansal et al., (2000)).   
 
Figure 3. Tumor slice volume (left y-axis) and corresponding relative (*) concentration 
of basic fibroblast growth factor (bFGF; right y-axis) over time (x-axis). (* = relative to 
the bFGF concentration at the time the first vessel docks on the tumor). 
 
Figure 4. Color-coded contours of the bFGF concentration gradient and resulting discrete 
vessel structure, with tumor contour in the center, at (a) t = 1,656 hrs (= “Spheroid” stage, 
Table 1), (b) t = 2,200 hrs, (c) t = 2,800 hrs (~ “1st Detectable Lesion” stage, Table 1), 
(d) t = 3,000 hrs, (e) t = 3,400 hrs, and (f) t = 3,800 hrs. 
 
Figure 5. Variations of structural properties of the vascular architecture over time (x-
axes): (a) branching length (average), (b) number of branching points for 24 hrs, and (c) 
vessel density of ROI (compare with Figure 1).  
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Figure 6. Fractal dimension of the vascular architecture during tumor growth, in a single 
run, at (a) t = 1,656 hrs, (b) t = 2,200 hrs, (c) t = 2,800 hrs, (d) t = 3,000 hrs, (e) t = 3,400 
hrs, and (f) t = 3,800 hrs. 
 
Figure 7. Fractal dimension of the vascular architecture (y-axis) over time (x-axis).  The 
error bars represent 10 runs with random vessel seed. 
 
Figure 8. Fractal dimension of the vascular architecture (y-axis) versus tumor slice 
volume (x-axis). The error bars represent 10 runs with random vessel seed. 
 
Figure 9. Color-coded contours of the bFGF concentration gradient and discrete vessel 
structure at t = 3,800 hrs, with variance in the deviation angle of the vessel sprout: (a) σ = 
0.3, (b) σ = 0.5 (i.e., the standard case, as detailed in Table 2), and (c) σ = 0.7. 
 
Figure 10. Fractal dimension of the vascular architecture (y-axis) versus time (x-axis) 
with different variance in the sprout’s deviation angle (see also Figure 9). 
 
Figure 11. Fractal dimension of the vascular architecture (y-axis) over time (x-axis) with 
varying tumor radii, r, at which the 1st vessel touches the tumor surface: (a) r=1.25, (b) 
r=1.5, and (c) r=1.75.  The error bars represent 10 runs with random vessel seed:  
 
Table 1. Approximate concentration of basic fibroblast growth factor (bFGF) released 
during each of the two consecutive growth stages (derived from a previously published 
model that simulates the growth of a brain tumor over several orders of magnitude 
(Kansal et al., 2000). (Note that in this model, “1st detectable lesion” was based on the 
reported conventional imaging detection limit at the time).  
 
Table 2. Values of model constants. 
 
Table 3. Values of the on-off style identifiers for the three regions of the tumor as 
described in the text and referred to in Figure 1. 
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Table 4. The circumferential angles (in degree) of the locations of the initial vascular 
branch that sprouts from the parent vessel. 
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 Growth Stage 
 Spheroid 1st Detectable lesion 
 
Tumor volume data 
Total volume (V)  
 
Total number of cells (Ntotal) 
 
Radius (R)  
 
 
 
0.5236 mm3 
 
106 
 
0.5 mm 
 
 
523.6 mm3 
 
109 
 
5 mm 
 
Tumor slice volume data 
Slice volume ( tRVS 2π= ) 
t = slice thickness (= 0.1 mm ) 
 
No. of cells per slice volume (Nslice) 
 
 
Proliferative and quiescent cell volume per 
slice (cell fraction) 
 
No. of cells per slice volume (Nslice) 
 
 
No. of viable cells in slice volume, Nviable = 
(proliferative + quiescent cell fraction) × 
Nslice 
 
 
 
0.07854 mm3 
 
 
1.5×105  
(106×0.07854/0.5236) 
 
0.0424 mm3 
(54 %) 
 
1.5×105  
(106×0.07854/0.5236) 
 
8.1×104 
 
 
7.854 mm3 
 
 
1.5×107 
(109×7.854/523.6) 
 
4.0 mm3 
(51 %) 
 
1.5×107 
(109×7.854/523.6) 
 
7.65×106 
 
Elapsed time of tumor growth 
(simulation results (Kansal et al., 2000)) 
 
 
69 days 
 
223 days 
 
bFGF production rate from Nviable tumor cells 
 
 
40.5 pg/24 h 
(8.1×104 ×50/105) 
 
 
3,825 pg/24 h 
(7.65 ×106 ×50/105) 
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Constant Notation Value Reference 
Diffusion coefficient for bFGF D 6 2 10.5 10 cm s− −×  Tong et al. (2001) 
Rate constant of bFGF uptake U 12000.0 m hµ −   Tong et al. (2001) 
Threshold concentration of bFGF Ct 0.001  Tong et al. (2001) 
Variance of deviation angle for vessel sprout σ 0.5 Tong et al. (2001) 
Rate constant of sprout formation  Smax 4 1 15 10 m hµ− − −×  Tong et al. (2001) 
Rate constant of bFGF degradation  K 2 12.89 10 h− −×  Tong et al. (2001) 
Initial volume in the Gompertz equation (Eq. (2)) V0 0.0042  Model fit to obtain 
the previous data 
(Kansal et al., 2000) 
Coefficients in the Gompertz equation (Eq. (2)) A 
B 
0.0033 
0.00017 
Model fit to obtain 
the previous data 
(Kansal et al., 2000) 
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Constant Values for each region 
µ1   0  for necrotic region, ΩN 
1  for viable tumor region, ΩV 
0  for healthy tissue region, ΩH 
µ2 1  for necrotic region, ΩN 
1  for viable tumor region, ΩV 
1  for healthy tissue region, ΩH 
µ3 1  for necrotic region, ΩN 
1  for viable tumor region, ΩV 
1  for healthy tissue region, ΩH 
µ4 0  for necrotic region, ΩN 
0  for viable tumor region, ΩV 
1  for healthy tissue region, ΩH 
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Table 4. 
